Some Methodological Considerations in Mendelian Randomization Studies Eric J. Tchetgen Tchetgen Depts of Epidemiology and Biostatistics.

Slides:



Advertisements
Similar presentations
June 25, 2006 Propensity Score Adjustment in Survival Models Carolyn Rutter Group Health Cooperative AcademyHealth, Seattle WA.
Advertisements

A workshop introducing doubly robust estimation of treatment effects
Department of Public Health and Primary Care, Cardiovascular Epidemiology Unit, Strangeways Research Laboratory, Cambridge, UK Mendelian randomization:
Study Designs in GWAS Jess Paulus, ScD January 30, 2013.
FTP Biostatistics II Model parameter estimations: Confronting models with measurements.
Improving health worldwide George B. Ploubidis The role of sensitivity analysis in the estimation of causal pathways from observational.
Sensitivity Analysis for Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ)
Revisiting causal neighborhood effects on individual ischemic heart disease risk: a quasi-experimental analysis among Swedish siblings Juan Merlo In collaboration.
Chance, bias and confounding
What is a sample? Epidemiology matters: a new introduction to methodological foundations Chapter 4.
What is Mendelian Randomisation? Frank Dudbridge.
SREE workshop march 2010sean f reardon using instrumental variables in education research.
FINAL REVIEW BIOST/EPI 536 December 14, Outline Before the midterm: Interpretation of model parameters (Cohort vs case-control studies) Hypothesis.
Model and Variable Selections for Personalized Medicine Lu Tian (Northwestern University) Hajime Uno (Kitasato University) Tianxi Cai, Els Goetghebeur,
Comparing Means: Independent-samples t-test Lesson 14 Population APopulation B Sample 1Sample 2 OR.
SOME ADDITIONAL POINTS ON MEASUREMENT ERROR IN EPIDEMIOLOGY Sholom May 28, 2011 Supplement to Prof. Carroll’s talk II.
Comparing Means: Independent-samples t-test Lesson 13 Population APopulation B Sample 1Sample 2 OR.
BIOST 536 Lecture 4 1 Lecture 4 – Logistic regression: estimation and confounding Linear model.
Are exposures associated with disease?
Cohort Study.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2014.
Epidemiology The Basics Only… Adapted with permission from a class presentation developed by Dr. Charles Lynch – University of Iowa, Iowa City.
TWO-STAGE CASE-CONTROL STUDIES USING EXPOSURE ESTIMATES FROM A GEOGRAPHICAL INFORMATION SYSTEM Jonas Björk 1 & Ulf Strömberg 2 1 Competence Center for.
AETIOLOGY Case control studies (also RCT, cohort and ecological studies)
Lecture 8: Generalized Linear Models for Longitudinal Data.
Lecture 6 Objective 16. Describe the elements of design of observational studies: (current) cohort studies (longitudinal studies). Discuss the advantages.
Introduction to Epidemiologic Methods Tuesday 9:30 – 10:30 am.
Marshall University School of Medicine Department of Biochemistry and Microbiology BMS 617 Lecture 8 – Comparing Proportions Marshall University Genomics.
Instrumental Variables: Problems Methods of Economic Investigation Lecture 16.
Bias Defined as any systematic error in a study that results in an incorrect estimate of association between exposure and risk of disease. To err is human.
A short introduction to epidemiology Chapter 2b: Conducting a case- control study Neil Pearce Centre for Public Health Research Massey University Wellington,
Lecture 7 Objective 18. Describe the elements of design of observational studies: case ‑ control studies (retrospective studies). Discuss the advantages.
Epidemiologic design from a sampling perspective Epidemiology II Lecture April 14, 2005 David Jacobs.
Assessing Binary Outcomes: Logistic Regression Peter T. Donnan Professor of Epidemiology and Biostatistics Statistics for Health Research.
MBP1010 – Lecture 8: March 1, Odds Ratio/Relative Risk Logistic Regression Survival Analysis Reading: papers on OR and survival analysis (Resources)
Analytical epidemiology Disease frequency Study design: cohorts & case control Choice of a reference group Biases Alain Moren, 2006 Impact Causality Effect.
Instrumental Variables: Introduction Methods of Economic Investigation Lecture 14.
Instructor Resource Chapter 14 Copyright © Scott B. Patten, Permission granted for classroom use with Epidemiology for Canadian Students: Principles,
1 Lecture 6: Descriptive follow-up studies Natural history of disease and prognosis Survival analysis: Kaplan-Meier survival curves Cox proportional hazards.
Case-Control Study Duanping Liao, MD, Ph.D
11/20091 EPI 5240: Introduction to Epidemiology Confounding: concepts and general approaches November 9, 2009 Dr. N. Birkett, Department of Epidemiology.
Sampling Design and Analysis MTH 494 Lecture-22 Ossam Chohan Assistant Professor CIIT Abbottabad.
BC Jung A Brief Introduction to Epidemiology - XIII (Critiquing the Research: Statistical Considerations) Betty C. Jung, RN, MPH, CHES.
Case-Control Studies Abdualziz BinSaeed. Case-Control Studies Type of analytic study Unit of observation and analysis: Individual (not group)
Practical With Merlin Gonçalo Abecasis. MERLIN Website Reference FAQ Source.
Matching. Objectives Discuss methods of matching Discuss advantages and disadvantages of matching Discuss applications of matching Confounding residual.
Chapter 3 Surveys and Sampling © 2010 Pearson Education 1.
Design of Clinical Research Studies ASAP Session by: Robert McCarter, ScD Dir. Biostatistics and Informatics, CNMC
Single-Subject and Correlational Research Bring Schraw et al.
Lecture 23: Quantitative Traits III Date: 11/12/02  Single locus backcross regression  Single locus backcross likelihood  F2 – regression, likelihood,
Matched Case-Control Study Duanping Liao, MD, Ph.D Phone:
G. Cowan Lectures on Statistical Data Analysis Lecture 9 page 1 Statistical Data Analysis: Lecture 9 1Probability, Bayes’ theorem 2Random variables and.
Introduction to Biostatistics, Harvard Extension School, Fall, 2005 © Scott Evans, Ph.D.1 Contingency Tables.
1 Borgan and Henderson: Event History Methodology Lancaster, September 2006 Session 8.1: Cohort sampling for the Cox model.
Table 1. Methodological Evaluation of Observational Research (MORE) – observational studies of incidence or prevalence of chronic diseases Tatyana Shamliyan.
Methods of Presenting and Interpreting Information Class 9.
Unmeasured Confounders (Ability) Those who have better ``ability’’ tend to have higher edu. and earn more! No College College.
Jeffrey E. Korte, PhD BMTRY 747: Foundations of Epidemiology II
Impact evaluation: The quantitative methods with applications
Figure 1 Mendelian randomization study
Correlation for a pair of relatives
Presenter: Wen-Ching Lan Date: 2018/03/28
Evaluating Impacts: An Overview of Quantitative Methods
Nat. Rev. Cardiol. doi: /nrcardio
Mendelian Randomization (Using genes to tell us about the environment)
Schematic representation of an MR analysis.
Effect Modifiers.
Björn Bornkamp, Georgina Bermann
Mendelian Randomization: Genes as Instrumental Variables
Presentation transcript:

Some Methodological Considerations in Mendelian Randomization Studies Eric J. Tchetgen Tchetgen Depts of Epidemiology and Biostatistics

What is Mendelian Randomization Use genotypes as instrumental variables (IVs) to estimate the causal health effects of phenotypes influenced by those genotypes MR methodology relies on strong assumptions Consider a recent study by Kivimaki et al AJE 2011 Causal DAG of Valid IV FTOBMIMD Unmeasured trait ? INTUITION behind IV estimand:“FTO->MD”=“FTO->BMI”x”BMI->MD”One can solve for ”BMI->MD”

More formal interpretation Suppose all variables are binary “Average effect in the compliers “ Suppose all variables are binary and the following monotonicity assumption holds: “FTO -> BMI” same direction for all individuals. Then the IV estimand of ”BMI->MD” =“FTO->MD” / “FTO->BMI” =The causal effect of BMI on MD in the subpopulation of individuals for whom “FTO -> BMI” is not zero “ Average effect in the exposed” If the causal effect ”BMI->MD” is the same for individuals with a high BMI regardless of their FTO status, Then the IV estimand of ”BMI->MD” =“FTO->MD” / “FTO->BMI” =The causal effect of BMI on MD among individuals with high BMI

More formal interpretation Suppose all variables are binary “Population Average effect ” If in subpopulation with a given BMI, the causal effect ”BMI->MD” is independent of their FTO status, Then the IV estimand of ”BMI->MD” =“FTO->MD” / “FTO->BMI” =The average causal effect of BMI on MD in the entire population

Is the IV the causal gene? Suppose all variables are binary “Average effect in the compliers “ Provided monoticity of causal gene and relation of FTO with (BMI,MD) only through KIAA1005 ”BMI->MD” =“FTO->MD” / “FTO->BMI” =The causal effect of BMI on MD amongst the subpopulation of individuals for whom “KIAA1005 -> BMI” is not zero “Average effect in the compliers and population Average effect “ equal to IV estimand as long as respective homogeneity assumption hold for the causal gene FTO BMIMD Unmeasured trait ? Gene in LD KIAA1005

Most GWAS are case-control studies Over sampling of cases introduces selection bias which induces violation of the IV assumption This connects to recent interest into methods for repurposing case-control samples Simple solution is to reweight sample to break the link between Diabetes and selection into case control sampling Matched density sampling, i.e. within risk sets, more complicated weighting scheme but can be done (Walter et al, 2012, in progress) FTOBMIMD Unmeasured trait ? DIABETES Case-control sample

Timing may be everything BMI is a lifecourse exposure, do we measure BMI at a time where it matters for MD. This is generally more severe than classical measurement error If we use either BMI(1) or BMI(2) alone, FTO is no longer be a valid IV, so –called exclusion restriction may not hold. Sometimes, people use the average of BMI(1) and BMI(2), this implicitly assumes that the effects are of the same magnitude Can use Robins Structural Nested models for average effect (Glymour et al, 2012, in progress) FTOBMI(1)MD Unmeasured trait ? BMI(2) ?

Survival analysis should be more powerful than binary regression Modeling time to MD should generally be more powerful than cumulative risk analysis Robins’ Structural nested AFT model an option, but can be difficult to implement with administrative censoring Structural Cox regression can be used to obtain a “compliers “ hazards ratio. (Tchetgen Tchetgen, 2012, in progress) Alternatively Structural nested additive hazards model can be used. (Tchetgen Tchetgen and Glymour, 2012, in progress) FTOBMIMD Unmeasured trait ?

Credible Mendelian Randomization The strong assumptions needed to identify the causal effects of a phenotype on a disease via MR will often not hold exactly These assumptions are not routinely systematically evaluated in MR applications, although such evaluation could add to the credibility of MR Approaches to Falsify an IV (Glymour, Tchetgen Tchetgen, Robins, AJE,2012): – Leverage prior causal assumption such as the known direction of confounding – Identify modifying subgroups – Instrumental inequality tests – Overidentification tests

MR Collaborators Maria Glymour Liming Liang Laura Kubzansky, Stefan Walter James Robins Shun-Chiao Chang Eric Rimm Marilyn Cornelis, Karestan Koenen Ichiro Kawachi Stijn Vansteelandt